Daratumumab monotherapy versus active monitoring in patients with high-risk smoldering multiple myeloma: Aquila outcomes based on mayo 2018/IMWG 2020 risk stratification, IMWG 2020 plus cytogenetic criteria, and age
Por:
Voorhees, P, Dimopoulos, M, Cohen, Y, Schjesvold, F, Hungria, V, Sandhu, I, Lindsay, J, Baker, R, Suzuki, K, Kosugi, H, Levin, MD, Beksac, M, Stockerl-Goldstein, K, Magen, H, Oriol, A, Mikala, G, Garate, G, Theunissen, K, Spicka, I, Mylin, A, Hallam, S, Bringhen, S, Uttervall, K, Pula, B, Khan, A, Medvedova, E, Ye, JC, Cowan, A, Moreau, P, Mateos, MV, Goldschmidt, H, Vieyra, D, Raval, A, Sha, LL, Li, L, Rousseau, E, Dennis, R, Carson, R and Rajkumar, SV
Publicada:
1 dic 2025
Ahead of Print:
1 dic 2025
Resumen:
Filiaciones:
Voorhees, P:
Wake Forest Univ, Levine Canc Inst, Atrium Hlth, Bowman Gray Sch Med, Charlotte, NC USA
Dimopoulos, M:
Natl & Kapodistrian Univ Athens, Athens, Greece
Cohen, Y:
Tel Aviv Sourasky Ichilov Med Ctr, Tel Aviv, Israel
Tel Aviv Univ, Gray Fac Med & Hlth Sci, Tel Aviv, Israel
Schjesvold, F:
Oslo Univ Hosp, Oslo Myeloma Ctr, Dept Hematol, Oslo, Norway
Univ Oslo, KG Jebsen Ctr B Cell Malignancies, Oslo, Norway
Hungria, V:
Clin Med Sao Germano, Sao Paulo, Brazil
Sandhu, I:
Cross Canc Inst, Edmonton, AB, Canada
Lindsay, J:
East Kent Hosp Univ NHS Fdn Trust, Kent & Canterbury Hosp, Canterbury, England
Baker, R:
Murdoch Univ, Perth Blood Inst, Perth, Australia
Suzuki, K:
Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan
Kosugi, H:
Ogaki Municipal Hosp, Ogaki, Japan
Levin, MD:
Albert Schweitzer Hosp, Dordrecht, Netherlands
Beksac, M:
Ankara Univ, Ankara, Turkiye
Stockerl-Goldstein, K:
Washington Univ, Sch Med, St Louis, MO USA
Magen, H:
Chaim Sheba Med Ctr, Ramat Gan, Israel
Tel Aviv Univ, Sackler Fac Med & Hlth Sci, Tel Aviv, Israel
:
Hosp Germans Trias i Pujol, Inst Catala Oncol, Barcelona, Spain
Hosp Germans Trias i Pujol, Inst Josep Carreras, Barcelona, Spain
Mikala, G:
South Pest Cent Hosp, Natl Inst Hematol & Infect Dis, Budapest, Hungary
Garate, G:
Hosp Aleman, Buenos Aires, Argentina
Theunissen, K:
Jessa Hosp, Hasselt, Belgium
Spicka, I:
Charles Univ & Gen Hosp, Prague, Czech Republic
Mylin, A:
Univ Copenhagen, Rigshosp, Copenhagen, Denmark
Hallam, S:
St Bartholomews Hosp, Dept Haematooncol, London, England
Queen Mary Univ London, London, England
Bringhen, S:
AOU Citta Salute & Sci Torino, SSD Clin Trials Oncol Ematol & Mieloma Multiplo, Turin, Italy
Uttervall, K:
Karolinska Univ Hosp, Med Unit Hematol, Stockholm, Sweden
Pula, B:
Inst Hematol & Transfus Med, Warsaw, Poland
Khan, A:
Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
Medvedova, E:
Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USA
Ye, JC:
Univ Texas MD Anderson Canc Ctr, Houston, TX USA
Cowan, A:
Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA USA
Moreau, P:
Univ Hosp Hotel Dieu, Nantes, France
Mateos, MV:
Univ Hosp Salamanca, IBSAL, Salamanca, Spain
IBMCC, Canc Res Ctr, Salamanca, Spain
Goldschmidt, H:
Heidelberg Univ Hosp, GMMG Study Grp, Internal Med Hematol Oncol & Rheumatol 5, Heidelberg, Germany
Natl Ctr Tumor Dis, Heidelberg, Germany
Vieyra, D:
Johnson & Johnson, Spring House, PA USA
Raval, A:
Johnson & Johnson, Raritan, NJ USA
Sha, LL:
Johnson &Johnson, Shanghai, Peoples R China
Li, L:
Johnson &Johnson, Shanghai, Peoples R China
Rousseau, E:
Johnson & Johnson, Beerse, Belgium
Dennis, R:
Johnson & Johnson, Raritan, NJ USA
Carson, R:
Johnson & Johnson, Spring House, PA USA
Rajkumar, SV:
Mayo Clin, Div Hematol, Rochester, NY USA
|